naltrexone has been researched along with Pervasive Child Development Disorders in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dove, D; McPheeters, ML; Sathe, NA; Taylor, JL; Veenstra-VanderWeele, J; Warren, Z | 1 |
Delaney, MA; Gratz, SS; Hyman, SB; Malone, RP | 1 |
Pachler, M; Scahill, L | 1 |
Sloman, L | 1 |
4 review(s) available for naltrexone and Pervasive Child Development Disorders
Article | Year |
---|---|
Medications for adolescents and young adults with autism spectrum disorders: a systematic review.
Topics: Adolescent; Adult; Age Factors; Antipsychotic Agents; Child; Child Development Disorders, Pervasive; Humans; Naltrexone; Narcotic Antagonists; Risperidone; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Young Adult | 2012 |
Advances in drug treatments for children and adolescents with autism and other pervasive developmental disorders.
Topics: Adolescent; Adrenergic alpha-Agonists; Antipsychotic Agents; Autistic Disorder; Central Nervous System Stimulants; Child; Child Development Disorders, Pervasive; Humans; Naltrexone; Nutrition Therapy; Selective Serotonin Reuptake Inhibitors; Vitamins | 2005 |
Treatment of hyperactivity in children with pervasive developmental disorders.
Topics: Adrenergic alpha-Agonists; Amantadine; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child Development Disorders, Pervasive; Child Psychiatry; Dopamine Agents; Guanfacine; Humans; Methylphenidate; Naltrexone; Narcotic Antagonists; Patient Selection; Treatment Outcome | 2007 |
Use of medication in pervasive developmental disorders.
Topics: Antipsychotic Agents; Attention Deficit Disorder with Hyperactivity; Autistic Disorder; Child; Child Development Disorders, Pervasive; Fenfluramine; Humans; Methylphenidate; Naltrexone; Psychotropic Drugs | 1991 |